
KALA BIO
KALA BIO is a clinical-stage biopharmaceutical company focused on rare and serious eye diseases.
$10M ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJun 15, 2010 (16 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Round | $10M | — | fundraisingfox.com |
Timeline
- Website created
Companies like KALA BIO
DDren Bio$350M Series B+ · Oct 2026RR1 Therapeutics$80.5M Series A · Sep 2026
BBionyra$165M Series A · Jun 2026
AAlzheon$100M Series B+ · Apr 2022
335PharmaSeries B+ · Nov 2024
VVaderis Therapeutics$152M Series B+ · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kala-bio (get a free API key).